Distinct gut microbiota but common metabolomic signatures between viral and MASLD HCC contribute to outcomes of combination immunotherapy.

Journal:
Hepatology
Published:
DOI:
10.1097/hep.0000000000001446
Affiliations:
6
Authors:
12
Go to article
Institutions Authors Share
Taipei Veterans General Hospital (TPEVGH), Taiwan
5.666667
 0.47
National Yang Ming Chiao Tung University (NYCU), Taiwan
4.333333
 0.36
Biotools Co. Ltd., Taiwan
2.000000
 0.17
Interested in Clinical Sciences?